# FDA Inspection 1183797 - BAYLX INC - October 06, 2022

Source: https://www.keypedia.com/records/fda_inspections/baylx-inc/d19eeab9-d56d-47db-b674-27383993dda3
Source feed: FDA_Inspections

> FDA Inspection 1183797 for BAYLX INC on October 06, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1183797
- Company Name: BAYLX INC
- Inspection Date: 2022-10-06
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1183797 - 2022-10-06](https://www.keypedia.com/records/fda_inspections/baylx-inc/d5baf595-19ba-4dc9-935b-1876fddf474e)
- [FDA Inspection 1183797 - 2022-10-06](https://www.keypedia.com/records/fda_inspections/baylx-inc/243b5cba-06f3-4fa3-ab52-a2fe93ecc4f6)

Company: https://www.keypedia.com/companies/baylx-inc/86eac4aa-9287-4095-aed7-c79278703eab

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d